Stock Analiz

CME Group Inc. (CME) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

CME Group’s revenue went from $3.6B in fiscal 2016 to $6.5B in fiscal 2025, growth of about 6.8% a year.

Net income in fiscal 2025 was $4.1B, a net margin of 62.5%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $7.0B and net income $4.4B.

Free cash flow was $4.2B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 6% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $3.6B162017: $3.6B172018: $4.3B182019: $4.9B192020: $4.9B202021: $4.7B212022: $5.0B222023: $5.6B232024: $6.1B242025: $6.5B25$6.5B
Net income
2016: $1.5B162017: $4.1B172018: $2.0B182019: $2.1B192020: $2.1B202021: $2.6B212022: $2.7B222023: $3.2B232024: $3.5B242025: $4.1B25$4.1B
Free cash flow
2016: $1.6B162017: $1.7B172018: $2.3B182019: $2.4B192020: $2.5B202021: $2.3B212022: $3.0B222023: $3.4B232024: $3.6B242025: $4.2B25$4.2B
EPS (diluted)
2016: $4.53162017: $11.94172018: $5.71182019: $5.91192020: $5.87202021: $7.29212022: $7.40222023: $8.86232024: $9.67242025: $11.1625$11.16

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$7.0B$6.5B$6.1B$5.6B$5.0B$4.7B$4.9B$4.9B$4.3B$3.6B$3.6B
Gross profit———————————
Operating income$4.6B$4.2B$3.9B$3.4B$3.0B$2.6B$2.6B$2.6B$2.6B$2.3B$2.2B
Net income$4.4B$4.1B$3.5B$3.2B$2.7B$2.6B$2.1B$2.1B$2.0B$4.1B$1.5B
EPS (diluted)$12.19$11.16$9.67$8.86$7.40$7.29$5.87$5.91$5.71$11.94$4.53
R&D———————————
Revenue growth—+6.4%+9.9%+11.2%+7.0%−4.0%+0.3%+13.0%+18.2%+1.4%+8.1%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$4.4B$4.3B$3.7B$3.5B$3.1B$2.4B$2.7B$2.7B$2.4B$1.8B$1.7B
Capital spending-$94M-$84M-$94M-$76M-$90M-$127M-$198M-$246M-$117M-$82M-$92M
Free cash flow$4.3B$4.2B$3.6B$3.4B$3.0B$2.3B$2.5B$2.4B$2.3B$1.7B$1.6B
Dividends paid$4.1B$3.9B$3.6B$3.2B$2.6B$2.2B$2.1B$1.7B$2.1B$2.0B$1.8B
Buybacks———————————
Stock-based pay$100M$95M$90M$83M$84M$75M$96M$73M$96M$58M$66M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$4.5B$3.0B$3.0B$2.8B$2.9B$1.7B$1.6B$1.4B$2.0B$2.0B
Debt—$3.4B$3.4B$3.4B$3.4B$3.4B$3.4B$4.3B$4.4B$2.2B$2.2B
Equity—$28.7B$26.5B$26.7B$26.9B$27.4B$26.3B$26.1B$25.9B$22.4B$20.3B
Total assets—$198.4B$137.4B$129.7B$174.2B$196.8B$124.7B$75.2B$77.5B$75.8B$69.4B
Shares (diluted)359M360M360M360M359M359M359M358M344M340M339M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin———————————
Operating margin65.7%64.9%64.1%61.6%60.1%56.4%54.0%53.2%60.5%63.4%61.2%
Net margin63.3%62.5%57.5%57.8%53.6%56.2%43.1%43.5%45.5%111.5%42.7%
FCF margin62.1%64.3%58.7%60.5%59.1%48.5%51.6%49.9%53.9%45.8%45.6%
ROIC—10.1%10.2%8.8%7.7%6.7%6.9%6.7%6.1%7.4%6.5%
ROE—14.2%13.3%12.1%10.0%9.6%8.0%8.1%7.6%18.1%7.5%

Frequently asked questions

What is CME Group’s annual revenue?

$6.5B in fiscal 2025 and $7.0B over the twelve months to September 30, 2026.

How much profit does CME Group make?

Net income was $4.1B in fiscal 2025 (net margin 62.5%).

Is CME Group’s revenue growing?

Yes: revenue rose 6.4% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.